4-4274442-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017816.3(LYAR):āc.757A>Cā(p.Lys253Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,613,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_017816.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LYAR | NM_017816.3 | c.757A>C | p.Lys253Gln | missense_variant | 7/10 | ENST00000343470.9 | NP_060286.1 | |
LYAR | NM_001145725.2 | c.757A>C | p.Lys253Gln | missense_variant | 7/10 | NP_001139197.1 | ||
LYAR | XM_011513505.2 | c.757A>C | p.Lys253Gln | missense_variant | 7/10 | XP_011511807.1 | ||
LYAR | XM_011513506.4 | c.757A>C | p.Lys253Gln | missense_variant | 6/9 | XP_011511808.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152068Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251282Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135794
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461646Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727134
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152068Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74258
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2024 | The c.757A>C (p.K253Q) alteration is located in exon 7 (coding exon 5) of the LYAR gene. This alteration results from a A to C substitution at nucleotide position 757, causing the lysine (K) at amino acid position 253 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at